Daniel Hunter

Daniel Hunter is currently a Principal at Exponent Private Equity, where they have been involved in significant acquisitions and sales, including the acquisition of Chanelle Pharma and the sale of Meadow to Fairfax Financial Holdings. They are an MBA candidate at INSEAD and previously held the role of Associate in the Private Equity group at Allen & Overy LLP, where they contributed to numerous multi-jurisdictional M&A transactions. Daniel also completed an exchange program at The Wharton School, enhancing their business acumen with courses in entrepreneurship and marketing. Daniel holds an Accelerated LPC with Distinction from The University of Law and a Master of Arts in Law from the University of Oxford.